Cargando…

Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling

The first line treatment for uncomplicated falciparum malaria is artemisinin-based combination therapy (ACT), which consists of an artemisinin derivative coadministered with a longer-acting partner drug. However, the spread of Plasmodium falciparum resistant to both artemisinin and its partner drugs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dini, Saber, Zaloumis, Sophie, Cao, Pengxing, Price, Ric N., Fowkes, Freya J. I., van der Pluijm, Rob W., McCaw, James M., Simpson, Julie A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2018
Materias:	Analytical Procedures
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201091/ https://www.ncbi.nlm.nih.gov/pubmed/30150462 http://dx.doi.org/10.1128/AAC.01068-18

Ejemplares similares

A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum
por: Cao, Pengxing, et al.
Publicado: (2017)

Modeling the dynamics of Plasmodium falciparum gametocytes in humans during malaria infection
por: Cao, Pengxing, et al.
Publicado: (2019)

Implications of population-level immunity for the emergence of artemisinin-resistant malaria: a mathematical model
por: Scott, Nick, et al.
Publicado: (2018)

Targeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance
por: Dogovski, Con, et al.
Publicado: (2015)

Enhancement of the Replication of Hepatitis C Virus Replicons of Genotypes 1 to 4 by Manipulation of CpG and UpA Dinucleotide Frequencies and Use of Cell Lines Expressing SECL14L2 for Antiviral Resistance Testing
por: Witteveldt, Jeroen, et al.
Publicado: (2016)

Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection
por: Kip, A. E., et al.
Publicado: (2016)

Lead Clinical and Preclinical Antimalarial Drugs Can Significantly Reduce Sporozoite Transmission to Vertebrate Populations
por: Upton, L. M., et al.
Publicado: (2014)

Usefulness of Serial Blood Sampling and PCR Replicates for Treatment Monitoring of Patients with Chronic Chagas Disease
por: Parrado, Rudy, et al.
Publicado: (2019)

Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays
por: Kavanagh, Angela, et al.
Publicado: (2018)

Improving Methods for Analyzing Antimalarial Drug Efficacy Trials: Molecular Correction Based on Length-Polymorphic Markers msp-1, msp-2, and glurp
por: Jones, S., et al.
Publicado: (2019)

Dried Blood Spot Technique-Based Liquid Chromatography-Tandem Mass Spectrometry Method as a Simple Alternative for Benznidazole Pharmacokinetic Assessment
por: Galindo Bedor, Danilo César, et al.
Publicado: (2018)

Validation and Application of Long-Read Whole-Genome Sequencing for Antimicrobial Resistance Gene Detection and Antimicrobial Susceptibility Testing
por: Weinmaier, Thomas, et al.
Publicado: (2022)

Mutant Prevention Concentration, Frequency of Spontaneous Mutant Selection, and Mutant Selection Window—a New Approach to the In Vitro Determination of the Antimicrobial Potency of Compounds
por: Krajewska, Joanna, et al.
Publicado: (2023)

Plasmodium falciparum: multifaceted resistance to artemisinins
por: Paloque, Lucie, et al.
Publicado: (2016)

Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia
por: Mairet-Khedim, Mélissa, et al.
Publicado: (2022)

Comparison of the Exposure Time Dependence of the Activities of Synthetic Ozonide Antimalarials and Dihydroartemisinin against K13 Wild-Type and Mutant Plasmodium falciparum Strains
por: Yang, Tuo, et al.
Publicado: (2016)

Nonlinear Mixed-Effects Modelling of In Vitro Drug Susceptibility and Molecular Correlates of Multidrug Resistant Plasmodium falciparum
por: Simpson, Julie A., et al.
Publicado: (2013)

Laboratory Detection of Artemisinin-Resistant Plasmodium falciparum
por: Chotivanich, Kesinee, et al.
Publicado: (2014)

Mechanisms of artemisinin resistance in Plasmodium falciparum malaria
por: Suresh, Niraja, et al.
Publicado: (2018)

The Mechanisms for Within-Host Influenza Virus Control Affect Model-Based Assessment and Prediction of Antiviral Treatment
por: Cao, Pengxing, et al.
Publicado: (2017)

A Multiscale Mathematical Model of Plasmodium Vivax Transmission
por: Anwar, Md Nurul, et al.
Publicado: (2022)

Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania
por: Mugittu, Kefas, et al.
Publicado: (2006)

Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia
por: Miotto, Olivo, et al.
Publicado: (2013)

Artemisinin‐naphthoquine for treating uncomplicated Plasmodium falciparum malaria
por: Isba, Rachel, et al.
Publicado: (2015)

Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
por: Wang, Jigang, et al.
Publicado: (2015)

Plasmodium falciparum rosetting protects schizonts against artemisinin
por: Lee, Wenn-Chyau, et al.
Publicado: (2021)

Plasmodium falciparum resistance to artemisinin-based combination therapies
por: Ward, Kurt E, et al.
Publicado: (2022)

The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study
por: Imwong, Mallika, et al.
Publicado: (2017)

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
por: van der Pluijm, Rob W, et al.
Publicado: (2020)

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
por: van der Pluijm, Rob W, et al.
Publicado: (2022)

Modelling the Effect of MUC1 on Influenza Virus Infection Kinetics and Macrophage Dynamics
por: Li, Ke, et al.
Publicado: (2021)

Enhanced viral infectivity and reduced interferon production are associated with high pathogenicity for influenza viruses
por: Li, Ke, et al.
Publicado: (2023)

Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development
por: Zaloumis, Sophie, et al.
Publicado: (2012)

TRACHEOSTOMY AND COVID-19 ARDS: ONE ACADEMIC CENTER’S EXPERIENCE
por: Kapp, Chris, et al.
Publicado: (2020)

FIBER-OPTIC BRONCHOSCOPY IN PATIENTS INFECTED WITH COVID-19: A CASE SERIES
por: Roa Gomez, Gabriella, et al.
Publicado: (2020)

BRONCHOPLEURAL FISTULA AS A COMPLICATION IN PATIENTS WITH COVID-19 MANAGED WITH ENDOBRONCHIAL VALVES
por: TALON, ANDREW, et al.
Publicado: (2021)

POST COVID-19 BRONCHOPLEURAL FISTULA WITH MULTIPLE PLEURAL DEFECTS AND PROLONGED CHEST TUBE MANAGED WITH ENDOBRONCHIAL VALVES TO AVOID ELOESSER FLAP AND CLAGETT PROCEDURE
por: TALON, ANDREW, et al.
Publicado: (2021)

BRONCHOSCOPY IN PATIENTS WITH COVID-19 ARDS ON MECHANICAL VENTILATION: A PROSPECTIVE STUDY
por: MEHTA, R., et al.
Publicado: (2022)

IMPACT OF TRACHEOSTOMY TIMING ON OUTCOMES IN COVID-19 AND NON-COVID-19 ARDS
por: GERIANI, D., et al.
Publicado: (2022)

LOWER RESPIRATORY TRACT SAMPLING VIA BRONCHOSCOPY IN COVID-19 ARDS: A FOCUS ON MICROBIOLOGY, CELLULAR MORPHOLOGY, CYTOLOGY, AND MANAGEMENT IMPACT
por: BANSAL, S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uk6lf3qt6rpqnh845r08snhdlb